Skip to main content
Premium Trial:

Request an Annual Quote

GeneLogic Moves into Agricultural Genomics, Acquires Oncormed

Premium

GAITHERSBURG, Md.--Gene Logic has announced a partnership with Hoechst Schering AgrEvo GmbH to develop novel crop protection and improvement products. A genomics company that has until now applied its products to human genome research, GeneLogic will construct an agricultural research database using its proprietary gene expression and bioinformatics technologies. Research and database fees paid by AgrEvo during the three-year term of the agreement could reach over $45 million, GeneLogic predicted. AgrEvo will also gain access to GeneLogic's proprietary Flow-Thru Chip technology for further analysis of genes identified in the research program.

GeneLogic also announced that it will acquire all outstanding Oncormed stock in a transaction valued at not more than $38 million. The combined company resulting from the merger will be a subsidiary of Gene Logic, based in Gene Logic's facility here. Gene Logic said Oncormed's proprietary technologies, resources, clinical experience, and portfolio of pharmacogenomics alliances will enable the combined companies to support aspects of drug discovery and development, including target identification and validation, the discovery of new drug leads, and clinical trials.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.